Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5
Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 have?
Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 has 98 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 published?
Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 has 2014 year in the ScholarIQ index.
What is the open-access status of Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5?
Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 has closed oa status in the ScholarIQ index.
What is the DOI of Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5?
The DOI for Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 is on the source record.
What is the PMID of Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5?
The PMID for Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 is on the source record.
What is the OpenAlex record for Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5?
The OpenAlex for Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: <scp>HARMONY</scp> 5 is on the source record.